Nov 13 (Reuters) – Merck & Co Inc: * MERCK RECEIVES POSITIVE EU CHMP OPINION TO EXPAND MARKETING AUTHORIZATION FOR ENFLONSIA® (CLESROVIMAB) TO INCLUDE CHILDREN UP TO 24 MONTHS OF AGE WHO REMAIN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Amy-Jo Crowley and Svea Herbst-Bayliss LONDON/NEW YORK, Nov 13 (Reuters) - Activist investor Sachem…
Manchester United fans remain sceptical about Pochettino appointment
VIDEO SHOWS: REACTION FROM MANCHESTER UNITED SUPPORTERS TO NEW MANAGER, MAURICIO POCHETTINO / OLD TRAFFORD…
EU sends Greece's PPC new objections in antitrust probe
BRUSSELS, Nov 13 (Reuters) - The European Commission said on Friday it had sent a…
